Navigation Links
SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers
Date:7/23/2009

Reston, Va.SNM's Clinical Trials Network today announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM's Clinical Trials Network is an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials.

According to Michael M. Graham, M.D., Ph.D., SNM President and co-chair of the Clinical Trials Network, "SNM is very pleased to have the support of Advanced Accelerator Applications, Erigal Limited and IBA Molecular. Their participation in the network will afford European clinical trial sites the option to obtain investigational imaging agents like FLT from a commercial provider instead of having to produce it themselves." These commercial manufacturers represent 27 PET manufacturing sites in Europe.

The SNM Clinical Trials Network has received investigational new drug (IND) status for the use of FLT in multicenter studies. The goal of the network is to receive multicenter IND status for additional imaging biomarkers over time. Each imaging site that participates in a study using an SNM multicenter IND will need to demonstrate that the biomarker for the study is manufactured in a manner consistent with FDA standards. Now, in place of submitting detailed information about in-house production methods, sites will have the option to purchase investigational biomarkers from a commercial manufacturer with a drug master file (DMF) on file with the FDA. Advanced Accelerator Applications, Erigal Limited and IBA Molecular have all expressed interest in participating in future multicenter clinical trials under SNM INDs. Participation in any specific trial will require that these manufacturers have chemistry, manufacturing and control (CMC) information on file with the FDA for the investigational imaging biomarker being used in that trial.

"We hope that having commerci
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., SOUTHFIELD, Mich., Dec. 1 /PRNewswire-FirstCa...: FMR ) ("First Mercury" or the "Company") annou...Directors declared a quarterly cash dividend of $0...areholders of record at the close of business on D...ancial Corporation ,, First Mercury Financial ...
(Date:12/1/2009)...es H1N1 vaccination because pandemic,s course rema...ealthDay News) -- A U.S. health official said Tues... the wane nationally, but many experts agreed the ..., The flu is now widespread in 32 states -- down f...en, director of the U.S. Centers for Disease Contr...
(Date:12/1/2009)... , RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNe...ated in 2001 and have expanded over the years serv.... The facility which was originally set up in an a...acy services, as part of the suite of services by ...dustry as a valuable offering. ,, The pharmacy ...
(Date:12/1/2009)..., WASHINGTON, Dec. 1 ... for International Development: ,, Chairman Ker...ttee. ,, I am honored to be nominated by Presid...States Agency for International Development, and I...y. ,, Secretary of State Clinton has expressed...
(Date:12/1/2009)...mber 1, 2009) The ADEAGies Foundation will honor ...ent Award at the Gies Awards celebration to be hel...unction with the 2010 ADEA Annual Session & Exhibi...ation, and Achievement recognize contributions to,...nitiatives. For a complete listing of Gies Award w...
Breaking Medicine News(10 mins):Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2
...tin is being hailed as a new 'wonder drug' after i... cancer patients. New results of the trials show t...for the cancer, something that has never happened ...apse as compared to 127 cases in patients who were...
...h Organization survey reveals that currently more ... in India, with more and more number of cases bein.../have already been initiated in 36 hospitals acros...s and promote community participation, of four-day...
...m solving, visual spatial processing, memory, and ...lcoholism. Smoking is much more prevalent among al...ssible neurocognitive effects of cigarette smoking...am from the USA set out to determine whether smoki...
... Radiation oncologist and Craig Greven, Vitreoreti...ting patients with malignant melanoma of uvea with...a rare tumor that occurs in only six per one milli...were reported in American Society for Therapeutic ...
...e version of the prescription weight-loss medicati...l? 120 mg) was found to be safe, effective and tol...ew data presented today at the 2005 Annual Meeting... with a body mass index (BMI) of 25 to 28, demonst...
...nister Dr. Manmohan Singh and Union Health Ministe...eting on how India can face the problem of bird fl...nti-viral drugs are very less in India compared to...le flu attack. Dr. Anbumani said the Ministry plan...
Other Medicine News:Health News:Condom Vending Machines To Be Installed Across Indian States 2Health News:Radiation therapy effective against Eye cancer 2Health News:Weight-Loss Medication Evaluated By Nutrition Expert 2
(Date:12/1/2009)...EN BURNIE, Md., Dec. 1 Sleep Solut...vice provider for home testing and evaluation of s...named Richard Hassett, M.D., as its chief executiv... Matria Healthcare, during its growth from a $250 ...lion industry leader in total population health, a...
(Date:12/1/2009)..., PISCATAWAY, N.J., Dec. 1 Siemen.../hearing) a leading global manufacturer of hearing...ip with Quota International,s Sound Beginnings pro...mber 2010. ,, As part of the renewed partnershi...chers for 100 free hearing instruments to both chi...
(Date:12/1/2009)..., CHENGDU, China, Dec. 1 /PRNewswire-Asia-Fi...E Amex: TPI ), a manufacturer and supplier of,mod... in Chengdu, China, today,announced that it has re...rug,Administration (SFDA) to produce Pediatric Fev...ube (SFDA approval number Z20093060) and Antibacte...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3PEER 1 Celebrates 10th Anniversary 59725 1PEER 1 Celebrates 10th Anniversary 59725 2PEER 1 Celebrates 10th Anniversary 59725 3
... Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) today...ampridine-SR in people with multiple sclerosis (MS...drew Goodman, M.D.,Director of the Multiple Scler...ted top-line results on walking ability, leg,stren...mpressions.,Dr. Goodman also presented a review of...
...onclinical (IND) In- Vitro,Studies for Promising A...SWIRE) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV...announce positive results were attained with its,l...spinol (SP-233),with well recognized in-vitro mod...mperfect predictors,of clinical responses, laborat...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
Demineralized Cortical Powder, DGC20
...dance system offers the Zone, a graphical illustra...curacy has been established in nonclinical testing...alue. It is simple to set up, intutive and easily ...igation and comes with the touchpad for sterile fi...
Occipito-Cervical System
Cushing Rongeur
Medicine Products: